United States

People: Vitrolife AB (VITRO.BE)

VITRO.BE on Berlin Stock Exchange

25 Sep 2017
Change (% chg)

€0.95 (+1.37%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Axelsson, Thomas 

Mr. Thomas Axelsson has served as Chief Executive Officer (CEO) of Vitrolife AB since November 17, 2011. He was, among other things, CEO of Stille and Artema. Currently, he is Member of the Board of Directors at Medivir AB. He has also been Chairman of the Board of Directors at SBL Vaccin AB, Neoventa Medical AB, Dipylon Medical AB (previously CMA Microdialysis AB) and Airsonett AB, among others. He was also Business Unit Director at Baxter. He holds a Master of Science degree.

Basic Compensation

Total Annual Compensation, SEK 4,927,000
Restricted Stock Awards, SEK --
Long-Term Incentive Plans, SEK --
All Other, SEK --
Fiscal Year Total, SEK 4,927,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --